The preparations are underway in full swing in Karnataka for the visit of the Leader of the Opposition in the Lok Sabha Rahul ...

Hyderabad: Despite clocking its highest-ever quarterly revenues during the first quarter ended June 30, pharma major Dr Reddy's Laboratories (DRL) on .

Dr. Reddy’s US generics business drags Q1 earnings, eyes weight-loss drug launch in 87 countries The drugmaker plans to launch Semaglutide in 87 countries next year, including those where ...

Dr. Reddy’s Labs Q1 net profit rises slightly despite U.S. market decline, focus on strengthening base business.

Komatireddy Rajgopal Reddy criticises Congress govt policies again; says Indiramma norms blocking housing for the poor Munugode MLA Komatireddy Rajgopal Reddy has criticised the Telangana government's ...

Dr Reddy's Laboratories' margins contracted to 26.7% from 28.2% in the year-ago period. The poll had estimated margins to be at 25.4%. The Street estimated revenue growth to be led by the integration ...

Q1 results today live updates, 23rd July 2025: Follow the FY26 Q1 results insights for the 52 companies like Infosys, TATA Consumer Products, Dr Reddy, Bajaj Housing Finance, Force Motors, Aditya ...

A 305-page chargesheet has laid out details of the scam which allegedly occurred during Jagan's tenure as chief minister.

Dr Reddy's Laboratories Q1 Results: Net Profit and Revenue in Q1 FY2026 However, on a quarter-on-quarter (QoQ) basis, the profit declined by 11%, while revenue remained largely flat.

Indian generic drugs maker Dr Reddy's Laboratories posted a narrow miss of quarterly profit expectations on Wednesday, as it struggled with pricing pressure on drugs and stiff competition in its ...

Dr Reddy's likely to see double-digit growth in revenue despite margin pressure, analysts predict Q1 FY26 results on July 23.

Dr Reddy's Laboratories Ltd on Wednesday posted a slight year-on-year (YoY) increase in profit after tax for the quarter ended June 30, 2025 (Q1 FY26), with PAT rising 2 per cent to Rs 1,417.8 ...